Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

Lilly is deploying biopharma’s most powerful AI Factory, built on the world’s first DGX B300 SuperPOD with over 1,000 ...

An agreement has been signed between the Sindh government’s Department of Empowerment of Persons with Disabilities and NED University to launch the project as a pilot scheme later this month. In the ...

While hospitals nationwide want to keep patients from regressing and requiring unplanned Intensive Care Unit (ICU) transfers, researchers from Northwell Health's Feinstein Institutes for Medical ...

Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...

This advancement is detailed in the journal Device and written by a team led by biomedical engineer Jung Seung Lee at ...

Anteris announced today it has received U.S. Food and Drug Administration (FDA) approval to initiate PARADIGM, its global Investigational Device Exemption (IDE) clinical trial which is designed to ...

The clinical success of PANVIS STAR signifies that China possesses the capability for independent R&D and clinical translation in the field of interventional robotics. Its pan-vascular compatibility ...

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...

A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ ...